1345
vs
A
0HF3
1345
A
0HF3
Over the past 12 months, China Pioneer Pharma Holdings Ltd has underperformed 0HF3, delivering a return of +3% compared to the 0HF3's +15% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
1345
0HF3
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
Intrinsic Value
2.14
HKD
Overvaluation 7%
A
0HF3
Intrinsic Value
502.14
USD
Undervaluation 36%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
China Pioneer Pharma Holdings Ltd
HKEX:1345
|
2.3
HKD
|
|||||
|
A
|
Amerisourcebergen Corp
LSE:0HF3
|
323.26
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
1345, 0HF3
1345, 0HF3
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
China Pioneer Pharma Holdings Ltd
Revenue
|
|||||||||||
|
A
|
Amerisourcebergen Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
1345, 0HF3
1345, 0HF3
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
China Pioneer Pharma Holdings Ltd
HKEX:1345
|
|||||||||
|
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
China Pioneer Pharma Holdings Ltd
48.9%
0HF3
3.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
China Pioneer Pharma Holdings Ltd | ||||
|
A
|
Amerisourcebergen Corp | ||||
Operating Margin
China Pioneer Pharma Holdings Ltd
12.4%
0HF3
1.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
China Pioneer Pharma Holdings Ltd | ||||
|
A
|
Amerisourcebergen Corp | ||||
Net Margin
China Pioneer Pharma Holdings Ltd
8.9%
0HF3
0.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
China Pioneer Pharma Holdings Ltd | ||||
|
A
|
Amerisourcebergen Corp | ||||
FCF Margin
China Pioneer Pharma Holdings Ltd
13.1%
0HF3
1.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
China Pioneer Pharma Holdings Ltd | ||||
|
A
|
Amerisourcebergen Corp | ||||
ROE
China Pioneer Pharma Holdings Ltd
10.6%
0HF3
152.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
China Pioneer Pharma Holdings Ltd | ||||
|
A
|
Amerisourcebergen Corp | ||||
ROA
China Pioneer Pharma Holdings Ltd
7.8%
0HF3
2.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
China Pioneer Pharma Holdings Ltd | ||||
|
A
|
Amerisourcebergen Corp | ||||
ROIC
China Pioneer Pharma Holdings Ltd
9.7%
0HF3
15.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
China Pioneer Pharma Holdings Ltd | ||||
|
A
|
Amerisourcebergen Corp | ||||
ROCE
China Pioneer Pharma Holdings Ltd
13.4%
0HF3
23.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
China Pioneer Pharma Holdings Ltd | ||||
|
A
|
Amerisourcebergen Corp | ||||
Solvency Comparison
China Pioneer Pharma Holdings Lt...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
1345, 0HF3
1345, 0HF3
Performance By Year
1345, 0HF3
1345, 0HF3
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 1345 to other stocks
MCK
Mckesson Corp
Cheaper
vs China Pioneer Pharma Holdings...
COR
Cencora Inc
Cheaper
vs China Pioneer Pharma Holdings...
CAH
Cardinal Health Inc
Cheaper
vs China Pioneer Pharma Holdings...
SIG
Sigma Healthcare Ltd
More expensive
vs China Pioneer Pharma Holdings...
Select Stock to Compare
| US |
|
Mckesson Corp
NYSE:MCK
|
|
| US |
|
Cencora Inc
NYSE:COR
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
